Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-24-052229

Chair and CEO sold 25,580 shares at an average $69.91 ($1,788,349)

  • Chair and CEO acquired 25,580 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lewis William · Chair and CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-19 Exercise or conversion : show line 1 in the form 10b5-1 +18,750 $22.76 $426,750 403,710 D
2024-12-19 Sale : show line 2 in the form 10b5-1 −13,162 $69.65 $916,733 390,548 D
2024-12-19 Sale : show line 3 in the form 10b5-1 −5,588 $70.52 $394,066 384,960 D
2024-12-19 Exercise or conversion : show line 4 in the form 10b5-1 +6,830 $10.85 $74,106 240,754 I
2024-12-19 Sale : show line 5 in the form 10b5-1 −5,240 $69.71 $365,280 235,514 I
2024-12-19 Sale : show line 6 in the form 10b5-1 −1,590 $70.61 $112,270 233,924 I
Open-market sales · 25,580 sh · avg $69.91 · $1,788,349

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-12-19 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) −18,750 112,500 D
2024-12-19 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) −6,830 232,290 I
Loading xslF345X05/wk-form4_1734729921.xml…